tradingkey.logo

Qiagen NV

QGEN
46.850USD
-0.080-0.17%
Cierre 10/10, 16:00ETCotizaciones retrasadas 15 min
10.16BCap. mercado
27.21P/E TTM

Más Datos de Qiagen NV Compañía

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Información de Qiagen NV

Símbolo de cotizaciónQGEN
Nombre de la empresaQiagen NV
Fecha de salida a bolsaSep 01, 1996
Director ejecutivoMr. Thierry Bernard
Número de empleados5765
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 01
DirecciónHulsterweg 82
CiudadVENLO
Bolsa de valoresNYSE Consolidated
PaísNetherlands
Código postal5912 PL
Teléfono31773556600
Sitio Webhttps://www.qiagen.com/
Símbolo de cotizaciónQGEN
Fecha de salida a bolsaSep 01, 1996
Director ejecutivoMr. Thierry Bernard

Ejecutivos de Qiagen NV

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables and Related Revenues
476.33M
89.28%
Instrumentation
57.21M
10.72%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
260.49M
48.82%
Europe & Middle East & Africa
179.30M
33.61%
Asia, Pacific & Rest of the World
73.46M
13.77%
Other Americas
20.29M
3.80%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables and Related Revenues
476.33M
89.28%
Instrumentation
57.21M
10.72%

Estadísticas de accionistas

Actualizado: jue., 11 de sep
Actualizado: jue., 11 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Wellington Management Company, LLP
12.00%
MFS Investment Management
10.83%
BlackRock Institutional Trust Company, N.A.
9.47%
The Vanguard Group, Inc.
4.22%
T. Rowe Price International Ltd
2.74%
Otro
60.74%
Accionistas
Accionistas
Proporción
Wellington Management Company, LLP
12.00%
MFS Investment Management
10.83%
BlackRock Institutional Trust Company, N.A.
9.47%
The Vanguard Group, Inc.
4.22%
T. Rowe Price International Ltd
2.74%
Otro
60.74%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
47.16%
Investment Advisor
33.17%
Research Firm
4.24%
Sovereign Wealth Fund
1.64%
Pension Fund
1.60%
Hedge Fund
1.43%
Holding Company
1.17%
Bank and Trust
1.02%
Individual Investor
0.44%
Otro
8.13%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
979
196.38M
90.57%
-12.64M
2025Q2
996
189.55M
87.53%
+6.64M
2025Q1
1017
179.03M
82.67%
+27.58M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Wellington Management Company, LLP
26.02M
12%
+1.59M
+6.49%
Jun 30, 2025
MFS Investment Management
23.48M
10.83%
-787.04K
-3.24%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
20.54M
9.47%
+174.28K
+0.86%
Sep 10, 2025
The Vanguard Group, Inc.
9.16M
4.22%
+372.54K
+4.24%
Jun 30, 2025
T. Rowe Price International Ltd
5.94M
2.74%
+1.79M
+43.10%
Jun 30, 2025
EARNEST Partners, LLC
4.20M
1.94%
+395.58K
+10.39%
Jun 30, 2025
Amundi Asset Management, SAS
3.98M
1.83%
-217.72K
-5.19%
Jun 30, 2025
DWS Investment GmbH
3.30M
1.52%
+2.74M
+482.72%
Jun 30, 2025
Swedbank Robur Fonder AB
3.30M
1.52%
-17.03K
-0.51%
Aug 31, 2025
Norges Bank Investment Management (NBIM)
3.30M
1.52%
-666.28K
-16.82%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
First Trust Nasdaq Lux Digi Health Solutions ETF
4.63%
Global X Genomics & Biotechnology ETF
4.01%
Invesco Biotechnology & Genome ETF
2.73%
Franklin Genomic Advancements ETF
1.65%
VanEck Biotech ETF
1.56%
ROBO Global Healthcare Technology & Innovation ETF
1.41%
Pacer US Large Cap Cash Cows Growth Leaders ETF
1.04%
iShares Health Innovation Active ETF
0.98%
Harbor Long-Short Equity ETF
0.84%
Burney US Factor Rotation ETF
0.78%
Ver más
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción4.63%
Global X Genomics & Biotechnology ETF
Proporción4.01%
Invesco Biotechnology & Genome ETF
Proporción2.73%
Franklin Genomic Advancements ETF
Proporción1.65%
VanEck Biotech ETF
Proporción1.56%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.41%
Pacer US Large Cap Cash Cows Growth Leaders ETF
Proporción1.04%
iShares Health Innovation Active ETF
Proporción0.98%
Harbor Long-Short Equity ETF
Proporción0.84%
Burney US Factor Rotation ETF
Proporción0.78%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Fecha
Tipo
Relación
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
KeyAI